glp 1 impact on bariatric surgery GLP1 After Surgery: What Every Patient Should Know SSAT Complex GS Fellowship Virtual

Prescribing information: WEGOVY (semaglutide) injection, for subcutaneous use, Food and Drug Administration (2025) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2025) Protect yourself from counterfeit and unsafe, mass compounded products, Eli Lilly FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) An overview of compounding, The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use (2020) FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) Paragraph IV patent certifications, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Mycopathologia 1995;131:107-14

Published February 18, 2026

Aaboe, K

Mechanisms of Ageing and Development, 2011